Fairmed Healthcare GmbH Synoptis Industrial Sp. z o.o.
PolandAll drugs from this manufacturer
-
The medicinal product is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.
Dosage form: capsules, hard
Active substance Dosage atomoxetine 10 mg ATC: N06BA09
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.
Dosage form: capsules, hard
Active substance Dosage atomoxetine 18 mg ATC: N06BA09
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.
Dosage form: capsules, hard
Active substance Dosage atomoxetine 25 mg ATC: N06BA09
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults (in adults, when symptoms are very troublesome and were present in childhood).
Dosage form: capsules, hard
Active substance Dosage atomoxetine 40 mg ATC: N06BA09
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.
Dosage form: capsules, hard
Active substance Dosage atomoxetine 60 mg ATC: N06BA09
-
Kamaptin is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.
Dosage form: capsules, hard
Active substance Dosage atomoxetine 80 mg ATC: N06BA09
-
The medicine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents, and adults.
Dosage form: capsules, hard
Active substance Dosage atomoxetine 100 mg ATC: N06BA09